Prognostic Factors at Initial Presentation and in Recurrent Disease

Nov 17, 2016 by in ONCOLOGY Comments Off on Prognostic Factors at Initial Presentation and in Recurrent Disease

“Good risk” (about 56 % of patients)    >90 % survival probability  Clinical presentation Low marker profile Non-seminoma Gonadal or retroperitoneal primary tumor and No extrapulmonary visceral metastases AFP < 1,000 ng/ml HCG < 5,000 U/l…

read more

How Should We Treat Clinical Stage I (CSI) Nonseminoma

Nov 17, 2016 by in ONCOLOGY Comments Off on How Should We Treat Clinical Stage I (CSI) Nonseminoma

Treatment Alla LVI + LVI − Surveillanceb BEP × 1c Surveillanceb BEP × 1c Surveillanceb BEP × 1c Number of patients 1,000 1,000 1,000 1,000 1,000 1,000 Relapses 250 21 500 32 150 16 Total number…

read more

Latest Recommendations of the European Germ Cell Cancer Group on Diagnosis and Treatment of Germ Cell Cancer

Nov 17, 2016 by in ONCOLOGY Comments Off on Latest Recommendations of the European Germ Cell Cancer Group on Diagnosis and Treatment of Germ Cell Cancer

Localization of the tumour Size Multiplicity Extension of the tumour (pT category according to UICC) Histopathological type (WHO) In seminoma: presence of syncytiotrophoblasts In spermatocytic seminoma: any sarcomatous elements In…

read more
Get Clinical Tree app for offline access